| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cytosine methylation 0.8816859804959318 2.188685851563155 0.0286196810281853 0.9999999743930048 1.0 5 P48735 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.6754747751797646 2.122880439320069 0.0337638719777515 0.9999999989525586 1.0 12 Q32P28,P13674,O15460,Q96AY3 4 |
| Cerebral organic acidurias including diseases 0.8495103549937931 2.0589876782478527 0.0394954188798215 0.9999999999708484 1.0 5 P48735 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7779373441175217 1.9268405603415697 0.0539995029607278 0.9999999999999968 1.0 6 Q15392,Q9UBM7,Q15738 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7708805474019715 1.896490775382912 0.0578951786338035 0.9999999999999998 1.0 6 P07099,Q14145 2 |
| Kennedy pathway from sphingolipids 0.8053920049581775 1.8783270994527952 0.0603364315378973 1.0 1.0 5 Q9Y6K0,Q9UG56,P35790,P48651 4 |
| Complement system 0.6269194443240211 1.863374092053638 0.0624096524749526 1.0 1.0 12 P04899,P48729,P17252,P26885,Q99829,Q07021 6 |
| Preimplantation embryo 0.6877684138480572 1.8159113942181608 0.069383965174949 1.0 1.0 8 P17096,Q9BTC8 2 |
| Ketogenesis and ketolysis 0.7357960162845794 1.7442967805742555 0.0811073527489474 1.0 1.0 6 P11166,O43772 2 |
| Triacylglyceride synthesis 0.7652733605287505 1.7114017431098874 0.0870069756365388 1.0 1.0 5 Q9HCL2 1 |
| Mitochondrial complex iv assembly 0.5831831947705497 1.6868917625120836 0.0916241663195418 1.0 1.0 13 P00403,Q7KZN9,P15954,P13073,P14406,Q9Y2R0,Q9Y6N1,P20674,O00483,P09669 10 |
| Mitochondrial long chain fatty acid betaoxidation 0.5403694998931019 1.5694151184018 0.1165512435745232 1.0 1.0 15 O43772,Q9BY49 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.7670645050606433 1.5665437514046625 0.1172213743598091 1.0 1.0 4 Q06136,Q9NRA0 2 |
| Glycerolipids and glycerophospholipids 0.7246799433832514 1.5402755330036897 0.1234932051039745 1.0 1.0 5 Q9HCL2,Q9UG56,P48651 3 |
| Adipogenesis 0.525782710476031 1.4829838238087103 0.1380787086280013 1.0 1.0 15 P17096,O00767,Q9NR56,P43490,P14174 5 |
| Glycerophospholipid biosynthetic pathway 0.5863715946759385 1.46419177935334 0.1431415557252577 1.0 1.0 9 Q9Y6K0,Q9HCL2,P48651 3 |
| Sphingolipid pathway 0.564630557226128 1.4615173644884762 0.1438735137221956 1.0 1.0 11 Q9NRA0,Q96G23,Q9Y5P4,Q06136,P62136 5 |
| Familial partial lipodystrophy fpld 0.6012930463054273 1.3903665942784955 0.1644175851101381 1.0 1.0 8 O75531,O60725 2 |
| Mitochondrial complex i assembly model oxphos system 0.5475592960955287 1.3169931516750222 0.1878409201136355 1.0 1.0 29 O75489,P51970,Q96CU9,O43676,Q9BUB7,Q9P0J0,P03886,Q8N183,Q9P032,O96000 10 |
| Oxidation by cytochrome p450 0.6367494819310671 1.305016222771766 0.1918873237921392 1.0 1.0 6 O43169 1 |
| Nanomaterial induced apoptosis 0.6359531244363604 1.301445104892636 0.1931061431065532 1.0 1.0 6 O95831 1 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.5014523155960741 1.2205847342704872 0.2222432891940904 1.0 1.0 13 P11166,P17096 2 |
| Riboflavin and coq disorders 0.6124118396066414 1.1957824525949212 0.2317814653044134 1.0 1.0 6 Q8NFF5,Q86YH6 2 |
| T cell receptor and costimulatory signaling 0.5994463910264181 1.1375744249853066 0.2552982309026519 1.0 1.0 6 P48729,Q15118 2 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.4667070091172628 1.1065694982208587 0.2684801008679676 1.0 1.0 16 P61978,P48729,P67870,Q13363,Q9HCK8,Q9UJX6 6 |
| Mitochondrial complex iii assembly 0.5177997945830325 1.09969453545336 0.2714652364864105 1.0 1.0 9 Q9Y276,Q9NVA1,Q9UDW1,Q6DKK2 4 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.5174117017420137 1.0976267242392057 0.2723675184205822 1.0 1.0 9 P49770,Q15118,P08069 3 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.5812436308453532 1.055969579449915 0.2909821132813848 1.0 1.0 6 P09601,Q14145 2 |
| Dopamine metabolism 0.741278155489534 1.0464652964540668 0.2953462593143598 1.0 1.0 3 P17252 1 |
| Influence of laminopathies on wnt signaling 0.4801742764952013 1.045114884062316 0.2959698757532985 1.0 1.0 12 O60725 1 |
| Endochondral ossification with skeletal dysplasias 0.5291541107032206 1.0290720718065975 0.3034458087817366 1.0 1.0 8 Q96QD8,P17252,P08069 3 |
| Endochondral ossification 0.5291541107032206 1.0290720718065975 0.3034458087817366 1.0 1.0 8 Q96QD8,P17252,P08069 3 |
| Estrogen receptor pathway 0.7333580479118662 1.0172707614342709 0.3090246418071352 1.0 1.0 3 Q9HCL2 1 |
| Nicotine effect on dopaminergic neurons 0.6010686946315387 1.0126374094403836 0.3112333843212544 1.0 1.0 5 P62136 1 |
| Ccl18 signaling pathway 0.4894163200387434 0.9962703120286504 0.3191188244076934 1.0 1.0 10 P11166,P08670,Q86UE4 3 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.5596110645567086 0.9593993891048934 0.3373575827436257 1.0 1.0 6 P09601,Q14145 2 |
| Genes related to primary cilium development based on crispr 0.4471890107253214 0.9585809231548568 0.3377699067159083 1.0 1.0 14 O95684,P63167,Q86SX3 3 |
| Rala downstream regulated genes 0.5587473869499786 0.9555577325327412 0.3392957245291339 1.0 1.0 6 P11233,Q96KP1,P16989 3 |
| Nipbl role in dna damage cornelia de lange syndrome 0.5825299352561525 0.9341313934633918 0.3502361198752421 1.0 1.0 5 Q13185,Q13315 2 |
| Dna mismatch repair 0.4556435788114787 0.933250293964657 0.3506907526048635 1.0 1.0 21 Q9NR33,Q9UQ84,P41440 3 |
| Overview of nanoparticle effects 0.9015479876161026 0.9215565659762992 0.3567599229701126 1.0 1.0 2 P09601 1 |
| Effect of progerin on genes involved in hutchinsongilford progeria syndrome 0.4314982323261576 0.9174748151293112 0.3588938842600717 1.0 1.0 15 Q13185,P83916,Q92769,Q12873,Q9BTC8,P45973 6 |
| Histone modifications 0.4833600368271604 0.916824310575495 0.3592347113505543 1.0 1.0 9 Q03164,O15047 2 |
| Aspirin and mirnas 0.6986683183648326 0.8906767094373245 0.3731026331184783 1.0 1.0 3 O15439,Q15118 2 |
| Metapathway biotransformation phase i and ii 0.4533716165674566 0.8791183245895208 0.3793371230362159 1.0 1.0 23 O15217,P07099,O43708,Q86UY6,Q6UW02 5 |
| Glycosylation and related congenital defects 0.4591520179273253 0.8789694161112649 0.3794178587850478 1.0 1.0 11 Q9H0U3 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.4481687747363082 0.865209841452878 0.3869236247357346 1.0 1.0 12 P48729,P67870,Q13363,Q9HCK8,Q86UE4 5 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4504877379823841 0.8621752004539471 0.3885911143909357 1.0 1.0 23 Q15392,Q14739,O00767,Q15738,P48449,Q9UBM7,O76062,Q9BWD1,Q15800 9 |
| Cholesterol biosynthesis pathway 0.4475461746956184 0.8617350343308076 0.3888333419331142 1.0 1.0 12 Q15738,P48449,Q9UBM7,Q15800 4 |
| Nrf2 pathway 0.4583706708929617 0.8493217196533146 0.3957022983144946 1.0 1.0 26 P11166,O15217,Q14145,Q14914 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.4169031093526676 0.8091069209157936 0.4184536476765537 1.0 1.0 16 P55209,P48729,O60725 3 |
| Vitamin a and carotenoid metabolism 0.5449521653118317 0.7774110756167446 0.4369162800570036 1.0 1.0 5 O94788,Q8WTV0 2 |
| Neuroinflammation 0.5441568257472017 0.7741414704975376 0.4388471357637804 1.0 1.0 5 Q8N9N2,O15111 2 |
| Mecp2 and associated rett syndrome 0.4316641488700355 0.7721318554511437 0.4400363367177906 1.0 1.0 22 P08069,P31943,P52597,Q99640,P35637 5 |
| Type 2 papillary renal cell carcinoma 0.4761909192661672 0.7671272983439502 0.4430058328853952 1.0 1.0 8 P11166 1 |
| Small cell lung cancer 0.3991500923627383 0.7260797224486208 0.4677898991256075 1.0 1.0 15 P31751,P63208,Q05397,O15111 4 |
| 1q211 copy number variation syndrome 0.4457006110182078 0.7203346666857424 0.4713189652637906 1.0 1.0 9 Q86WJ1,Q07157,Q9Y624 3 |
| Lung fibrosis 0.5049238128176841 0.7198945064169295 0.4715899506902359 1.0 1.0 6 P09601 1 |
| Mirnas involved in dna damage response 0.5560718711276293 0.7154099018526634 0.4743557957647777 1.0 1.0 4 P16104,Q13315,P04637 3 |
| Hedgehog signaling pathway wp4249 0.499386880725171 0.6962419440021463 0.4862773241242317 1.0 1.0 6 P48729 1 |
| Nucleotide excision repair 0.4275341391715038 0.6531554718624558 0.513656053467904 1.0 1.0 27 P41208,P54725,Q9NR33,P41440 4 |
| Camkk2 pathway 0.4085660387976763 0.6477200050119991 0.5171660629021273 1.0 1.0 12 P09601 1 |
| Ethanol effects on histone modifications 0.4040212371208547 0.6233799309881192 0.533034882957665 1.0 1.0 12 P00374,P41440 2 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.6180512925801693 0.6101523860759738 0.5417608672471155 1.0 1.0 3 P17252 1 |
| Autophagy 0.4592837609375836 0.5997872589386245 0.5486480256596531 1.0 1.0 7 Q9Y4P8 1 |
| Progeriaassociated lipodystrophy 0.4128850739370114 0.5918197831494163 0.5539712742380651 1.0 1.0 10 O60725 1 |
| Burn wound healing 0.4558994494753309 0.5850113119545113 0.5585401106459433 1.0 1.0 7 P31949,P08670 2 |
| Congenital generalized lipodystrophy cgl 0.7919504643962848 0.56963943848567 0.5689222735709023 1.0 1.0 2 P62993 1 |
| Apoptosis modulation and signaling 0.3665739883913808 0.5401064737706768 0.5891236063967797 1.0 1.0 15 O95831 1 |
| Nrf2are regulation 0.4070789940535863 0.5271328039089139 0.5981013679413931 1.0 1.0 9 Q14145 1 |
| Sphingolipid metabolism overview 0.4200077416246615 0.5033349931114048 0.6147287676994704 1.0 1.0 8 Q9NRA0,Q06136,Q96G23 3 |
| Wnt signaling 0.3562940888162231 0.4836635466966232 0.6286246679363063 1.0 1.0 15 P48729,Q8TAA9,P67870,P17252,Q9HCK8 5 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.4471926740228892 0.4823439931573313 0.6295616002116153 1.0 1.0 6 O15111 1 |
| Wntbetacatenin signaling pathway in leukemia 0.4649010146485747 0.4651173201884838 0.6418474432438961 1.0 1.0 5 P48729 1 |
| Osteoclast signaling 0.7442724458204347 0.4350026225173482 0.6635605238695936 1.0 1.0 2 O75348 1 |
| Tumor suppressor activity of smarcb1 0.3441094187130998 0.4186186510410935 0.6754948565832308 1.0 1.0 15 Q92925,P11802,Q92922,Q15910,Q8TAQ2,Q12824,O96019,Q969G3,Q09028,Q96GM5,P51532,Q15022,Q00534,O75530 14 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.5556233450416251 0.4161630299064919 0.6772907104852348 1.0 1.0 3 P31751 1 |
| Mitochondrial immune response to sarscov2 0.3807751158640592 0.4036803160546772 0.686447816140809 1.0 1.0 9 P35232,Q9Y276,Q7Z434 3 |
| S1p receptor signal transduction 0.3715989568937921 0.3627201585728973 0.7168139394669222 1.0 1.0 9 P04899,Q9NRA0,P08754 3 |
| Endoplasmic reticulum stress response in coronavirus infection 0.4010198733960376 0.3597468818509949 0.7190364293070699 1.0 1.0 7 Q15435,P62136 2 |
| Tryptophan metabolism 0.3296362837235472 0.3444697379784461 0.7304930506305995 1.0 1.0 15 Q15392,Q16836 2 |
| Canonical and noncanonical notch signaling 0.5287690048681458 0.342090578786065 0.7322827272616379 1.0 1.0 3 O15111 1 |
| Orexin receptor pathway 0.3457446041093137 0.3233542800534152 0.7464269504173244 1.0 1.0 21 P17096,Q14202,P50336,P17252,Q15118,Q13595,P11166 7 |
| Atr signaling 0.441074270978659 0.3188398991302966 0.7498479208982112 1.0 1.0 4 O60921,Q8WXE1 2 |
| Striated muscle contraction pathway 0.4020666571382959 0.3168650254427099 0.7513460212120504 1.0 1.0 6 P08670,P28289 2 |
| Dna damage response 0.3388854077827592 0.2749602317511648 0.7833467915382135 1.0 1.0 22 P15927,P41440 2 |
| Oxidative phosphorylation 0.3716132384125438 0.2657190867064378 0.7904555626112819 1.0 1.0 33 Q15904,O75489,P56385,O96000,P56134,O75438,O75964,P51970,P03886,O00217,O00483,Q16795 12 |
| Electron transport chain oxphos system in mitochondria 0.4314819348244333 0.2630017177267014 0.7925492551570323 1.0 1.0 55 O75489,Q7KZN9,P56385,P12235,P03886,Q9UDW1,O75438,O95169,Q9UII2,Q16795,O96000,P00403,P15954,O75964,O43676,P14406,O00217,P09669,P56134,P13073,P51970,P21912,P20674,Q9Y6N1,P05141,O00483 26 |
| Proximal tubule transport 0.3233521294663851 0.2578146138372322 0.7965499854587152 1.0 1.0 13 P11166 1 |
| Neuroinflammation and glutamatergic signaling 0.3334609372736572 0.2500426360830051 0.8025543767820398 1.0 1.0 22 O94925,P78330,P17252,P62140,P62136,Q96QD8,P11166 7 |
| Interactome of polycomb repressive complex 2 prc2 0.3702325581395383 0.2493765455964284 0.8030695260591787 1.0 1.0 7 Q15910,Q09028,Q9NYF8,Q16576,Q15022,O75530 6 |
| Mirna regulation of dna damage response 0.3364005625735689 0.2485358743898161 0.8037198168613124 1.0 1.0 23 P15927,P41440 2 |
| Purinergic signaling 0.3910394007986896 0.22792273226347 0.8197063100050046 1.0 1.0 5 P04899,P08754 2 |
| Metastatic brain tumor 0.4769278414369753 0.2195958209379614 0.8261859463823349 1.0 1.0 3 Q00534,P04637 2 |
| Novel intracellular components of rigilike receptor rlr pathway 0.323224682449257 0.2102362303179417 0.8334833036843741 1.0 1.0 11 Q92841,Q7Z434,Q13526,O15111 4 |
| Mirna regulation of p53 pathway in prostate cancer 0.6439628482972171 0.2094368123112425 0.8341072578482551 1.0 1.0 2 Q13315 1 |
| Tp53 network 0.6439628482972171 0.2094368123112425 0.8341072578482551 1.0 1.0 2 Q13315 1 |
| Sphingolipid metabolism integrated pathway 0.3316151430569429 0.2008083520002864 0.8408484320041736 1.0 1.0 9 Q9NRA0,Q06136,Q96G23 3 |
| Estrogen signaling pathway 0.3527662633261705 0.1934774166432661 0.8465850908092154 1.0 1.0 7 P17252 1 |
| Sars coronavirus and innate immunity 0.625077399380816 0.1774171969300752 0.8591807003902652 1.0 1.0 2 Q7Z434 1 |
| Ovarian infertility 0.4546299163827835 0.1762713734850652 0.8600807505251642 1.0 1.0 3 P11802,Q13315 2 |
| Ras signaling 0.3511995524238078 0.1643736677080005 0.8694369917332943 1.0 1.0 34 P62993,P31751,Q96KP1,P08069,O15111,P17252,P11233,P62330,P20339,Q9UQ13,Q7Z569,P0DP25 12 |
| Sphingolipid metabolism in senescence 0.3089678711573276 0.1568370709577229 0.8753732559759269 1.0 1.0 11 Q06136,P17252 2 |
| Heme biosynthesis 0.3511563789263097 0.1313850847130629 0.8954706870559779 1.0 1.0 5 P06132,P50336 2 |
| Photodynamic therapyinduced hif1 survival signaling 0.2943571501539747 0.1231896954284548 0.9019568852726448 1.0 1.0 12 P11166 1 |
| Hepatitis b infection 0.3082824913017369 0.1188394284834134 0.9054025705984804 1.0 1.0 24 P62993,P31751,Q15904,Q7Z434,O15111,P17252,Q9Y277 7 |
| Onecarbon metabolism and related pathways 0.2794667928776964 0.1052205996574638 0.9162007652910646 1.0 1.0 14 Q9Y6K0,P04179,P34896,P35790 4 |
| Myometrial relaxation and contraction pathways 0.2896764595295852 0.098827696910799 0.9212750771831985 1.0 1.0 20 P31946,P17252,Q99439,P0DP25 4 |
| Fluoropyrimidine activity 0.2869565217391183 0.0985799343073502 0.9214718025082572 1.0 1.0 12 P00374,P18074,Q92820,P31350,P04818,O15439,Q06203,P04183,Q99808,P11172,P04637 11 |
| Kisspeptinkisspeptin receptor system in the ovary 0.3095297947804797 0.0972844783952864 0.9225004819748566 1.0 1.0 8 P17252,Q15118 2 |
| Spinal cord injury 0.2891665304713779 0.0970211059317089 0.922709633408733 1.0 1.0 20 P04083,P14174,P17931,P17252 4 |
| Tlr4 signaling and tolerance 0.3405144988674237 0.0946296426900443 0.9246090040192598 1.0 1.0 4 O15111 1 |
| Common pathways underlying drug addiction 0.2988147293594417 0.0930485567513138 0.9258649858095233 1.0 1.0 9 P17252,P62136 2 |
| Ciliopathies 0.2820300553664516 0.0837853882865659 0.9332270656252872 1.0 1.0 19 Q13432,P57076 2 |
| Pyrimidine metabolism 0.3476027221834088 0.083720655841566 0.93327853381323 1.0 1.0 40 Q9H773 1 |
| Signal transduction through il1r 0.3220282445842298 0.0774020305195319 0.9383037255096852 1.0 1.0 5 O15111 1 |
| Ptf1a related regulatory pathway 0.3745688768848979 0.0697265871710916 0.9444112797757565 1.0 1.0 3 Q06330 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.2950087643949025 0.0500777900661441 0.9600603984870082 1.0 1.0 7 P51148,P20339,P31943 3 |
| Egfegfr signaling pathway 0.3319145638483523 0.0410385806401499 0.967265138852884 1.0 1.0 39 P30086,P17252,Q9P0J0,P11233,P62330,Q96J02,P40818,Q05397 8 |
| Hippo signaling regulation pathways 0.2605322726704179 0.03684169918014 0.9706112254642708 1.0 1.0 17 P04899,P17252,P08069 3 |
| Extracellular vesiclemediated signaling in recipient cells 0.2865551425030856 0.0349327641984083 0.9721333544971852 1.0 1.0 4 P25054,Q9NWH9,P42345 3 |
| Ras and bradykinin pathways in covid19 0.3022607618457665 0.0297507144563835 0.97626586551426 1.0 1.0 3 Q99829,P28482 2 |
| Head and neck squamous cell carcinoma 0.2542935049403911 0.0286782361178046 0.9771212142896206 1.0 1.0 16 Q14145 1 |
| Nonalcoholic fatty liver disease 0.364383474794746 0.0283730459238669 0.9773646217805572 1.0 1.0 52 O75489,Q9UDW1,P31751,O75438,O95169,Q9P0J0,Q16795,O96000,P00403,P15954,O43676,P14406,Q96J02,O00217,P09669,P13073,P51970,P21912,P20674,O00483 20 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.2818604651162825 0.0269363275772923 0.9785105188046688 1.0 1.0 7 Q8WX92,Q92769,P50750,O00267,Q8IXH7,O94992 6 |
| Disruption of postsynaptic signaling by cnv 0.2797114908763044 0.0234875542341718 0.9812613660300948 1.0 1.0 7 Q07157,P61981 2 |
| Mammary gland development pathway involution stage 4 of 4 0.3637770897832826 0.0211714800369953 0.9831088648152262 1.0 1.0 2 P04637 1 |
| Notch signaling 0.2633960575128271 0.0002659659815689 0.9997877898521093 1.0 1.0 7 Q06330,Q13363 2 |
|
|
